Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

New treatments for male hypogonadism are effective and should be personalized.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Fibroblasts are important in healing diabetic wounds, but high sugar levels can harm their function and slow down the healing process.

Tadalafil is effective for treating urinary symptoms in men with BPH.

New liposomal formulations may improve delivery of treatments to hair follicles, potentially helping with hair loss.

Stress can stop hair growth in mice, and treatments can reverse this effect.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Alopecia areata involves immune response and gene changes affecting hair loss.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Hair loss causes stress and affects mental health; treatment and support needed.

Nerves and chemicals in the body can affect hair growth and loss.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Stress can worsen skin conditions and stop hair growth by affecting the body's stress response system.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.

Taking tamsulosin or finasteride and being older increase the risk of floppy iris during cataract surgery.